US expert consensus on defining intolerance to tyrosine kinase inhibitor treatment in chronic phase chronic myeloid leukemia (CML) Meeting Abstract
| Authors: | Atallah, E. L.; Broder, M. S.; Chan, O.; Dalglish, H.; Flynn, K. E.; Gilreath, J.; Hine, M.; Hunter, A. M.; Mauro, M. J.; Pinilla-Ibarz, J.; Rein, L. A. M.; Shah, N. P.; Stemper, E.; Tantravahi, S. K.; Yang, J. Y. |
| Abstract Title: | US expert consensus on defining intolerance to tyrosine kinase inhibitor treatment in chronic phase chronic myeloid leukemia (CML) |
| Meeting Title: | 66th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 144 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2024 Dec 7-10 |
| Meeting Location: | San Deigo, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2024-11-05 |
| Start Page: | 5052 |
| End Page: | 5053 |
| Language: | English |
| ACCESSION: | WOS:001422356200012 |
| DOI: | 10.1182/blood-2024-194617 |
| PROVIDER: | wos |
| Notes: | Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work